FDA recall record

Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours recall — FDA D-1372-2012

Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the…

Class IIclassification
D-1372-2012official record ID
Jun 20, 2012report date

Recall record at a glance

Official recordD-1372-2012
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmNoven Pharmaceuticals, Inc.
Report dateJun 20, 2012
Recall initiation dateJul 5, 2011
Quantity357,510 patches
LocationMiami, FL, United States

Official product description

Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, labeled as a) Manufactured for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 54092-554-30; b) Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5554-3.

Why the product was recalled

Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

Distribution information

Nationwide and Puerto Rico.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugDec 7, 2022

Daytrana recall — FDA D-0071-2023

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJul 6, 2022

Daytrana recall — FDA D-1169-2022

Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJun 1, 2022

Daytrana recall — FDA D-0889-2022

Defective Delivery System: customer complaints exceeded respective action limits.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.